Concepedia

Lingnan Li

LL

13

Publications

670

Citations

11

H-Index

2009

Active since

Affiliations

State Key Laboratory of Natural Medicine(Current)

China Pharmaceutical University

Medical University of Vienna

Eli Lilly (United States)

Swedish Medical Center

Lingnan Li is an author at State Key Laboratory of Natural Medicine specializing in pharmacology, medicine, and medicinal chemistry.

Top concepts

Publications per year

2009–2020

13

Publications

13

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial

Philip J. Mease, Josef S Smolen, Frank Behrens et al. · Annals of the Rheumatic Diseases · 2019 · 280 citations · Full text

Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52

Josef S Smolen, Philip J. Mease, Hasan Tahir et al. · Annals of the Rheumatic Diseases · 2020 · 79 citations · Full text

Pathogenic adaptations of Colletotrichum fungi revealed by genome wide gene family evolutionary analyses

Xiaofei Liang, Bo Wang, Qiuyue Dong et al. · PLoS ONE · 2018 · 72 citations · Full text

Efficacy and Safety of Ixekizumab with or Without Methotrexate in Biologic-Naïve Patients with Psoriatic Arthritis: 52-Week Results from SPIRIT-H2H Study

Josef S Smolen, Anthony Sebba, Eric Ruderman et al. · Rheumatology and Therapy · 2020 · 43 citations · Full text

Effects of Gnaphalium affine D. Don on hyperuricemia and acute gouty arthritis

Hongjian Zhang, Lingnan Li, Jie Zhou et al. · Journal of Ethnopharmacology · 2017 · 36 citations

, , +11

Rows per page

1–5 of 13